TRUHEALTH Heart Advance is a premium cardiac risk–assessment package designed to detect early signs of heart disease by analysing advanced heart-specific biomarkers. It evaluates inflammation, plaque activity, lipid particle behaviour, and cardiac muscle injury through tests like Apo A1/B, Homocysteine, HsCRP, Lp-PLA2, Lipoprotein(a), and High-sensitivity Troponin-I. These markers provide deep insight into cardiovascular risk beyond routine lipid profiles. Conducted with precision by Metropolis Healthcare, this package supports proactive heart-health management and early detection of hidden cardiac threats.
17 Crores+ Samples Processed
World Class Technology Labs
25+ Years of Trust & Experience
Free Home Collection
Price:
₹ 6,000.00
100 Booked This Week
Sample Type: Gel Vacutainer
10-12 hrs fasting is required (Only water is allowed)
List of Profiles Included:
Notes:T5610
Frequently Asked Questions (FAQ's):
What does the TRUHEALTH Heart Advance package include at Metropolis Healthcare?
It includes Apo A1/B, Homocysteine, HsCRP, Lp-PLA2, Lipoprotein(a), and Hs Troponin-I—advanced markers assessed at Metropolis Healthcare for comprehensive cardiac evaluation.
How does Metropolis Healthcare measure heart-specific biomarkers?
Metropolis Healthcare uses high-sensitivity, high-precision analyzers to measure inflammation, plaque activity, and cardiac injury markers accurately.
Who should take the TRUHEALTH Heart Advance package?
Anyone with a family history of heart disease, high cholesterol, diabetes, hypertension, or lifestyle risk factors can benefit from this Metropolis Healthcare cardiac package.
Is fasting required for these heart tests at Metropolis Healthcare?
Fasting is not mandatory for most markers, but Metropolis Healthcare may advise fasting depending on your concurrent test requirements.
Why are Apo A1/B and Lp(a) included in this Metropolis Healthcare heart package?
They assess genetic and lipid-related cardiovascular risks, providing deeper insight into heart health compared to a standard lipid profile.
What does Lp-PLA2 (PLAC) indicate in this package?
Lp-PLA2 helps detect active arterial inflammation and plaque instability—key contributors to the risk of heart attack.
How does Hs Troponin-I help in early heart-disease detection?
This high-sensitivity marker identifies even tiny amounts of cardiac muscle injury, supporting early detection at Metropolis Healthcare.
When will I receive my TRUHEALTH Heart Advance results from Metropolis Healthcare?
Reports are generally delivered within the standard Metropolis Healthcare reporting timeline through digital access.